• Event Type: Q1 FY27 Post Results Earnings Conference Call with Investors/Analysts.
  • Event Date and Time: Held on August 17, 2026. Specific time not mentioned in the transcript.
  • Purpose of Event: Discussion of Q1 FY27 financial results, operational updates, order book status, strategic initiatives including cell manufacturing and BESS plans, and addressing analyst questions.
  • Earnings Announcement Timing: The call was held after the earnings announcement for Q1 FY27.
  • Management Participants: Dr. Chetan Shah (Chairman and Managing Director), Mr. Vipul Shah (Non-Executive Director), Mr. Hemal Kachiwala (Chief Financial Officer). The call was moderated by Mr. Rushabh Shah from ADFACTORS PR.
  • Availability of Materials: The transcript of the call is the enclosed document submitted to the exchanges. No mention of presentation decks or recordings being hosted elsewhere.
  • UPSI Statement: The moderator's opening remarks included a standard caution that forward-looking statements involve risks and uncertainties, but there was no explicit statement that no UPSI would be shared.

Financial Highlights Discussed:

  • Q1 FY27 Revenue: INR 265.6 crore, up 1.8% YoY from INR 261 crore in Q1 FY26.
  • Q1 FY27 EBITDA: INR 33.8 crore (Margin: 12.7%), down from INR 42.7 crore (Margin: 16.4%) in Q1 FY26.
  • Q1 FY27 Depreciation: INR 10.2 crore, up from INR 4.3 crore in Q1 FY26.
  • Q1 FY27 Finance Cost: INR 12.5 crore, up from INR 5.4 crore in Q1 FY26.
  • Q1 FY27 PBT: INR 11.1 crore.
  • Q1 FY27 PAT: INR 8.3 crore (PAT Margin: 3.1%).
  • Q1 FY27 EPS: INR 7.39.
  • FY27 Guidance Reaffirmed: Revenue guidance and PAT margin in the range of 5% to 6% maintained.

Operational and Strategic Updates:

  • BSE Listing: Completed listing on BSE Limited (existing shares, no fresh capital raised). Company now listed on both NSE and BSE with over 11,000 shareholders.
  • Order Book: Total visibility stands at approximately INR 3,400 crore across confirmed POs, signed MSAs, and advanced discussions. New orders worth INR 845.84 crore secured for execution by December 31, 2026.
  • Manufacturing Capacity: 4 GW module manufacturing capacity in Tadkeshwar, Gujarat is operational. FY27 average utilization assumption is around 55%.
  • Cell Manufacturing Project: 2.2 GW N-type TOPCon+ cell line (first phase of 5 GW plan) on track for commissioning by end of calendar year 2027. Land parcel in closing stage. Funding: ~INR 700 crore debt at advanced discussion stage; ~INR 350 crore equity via NCDs/CCDs in due diligence. Partnering with an experienced TOPCon cell manufacturer for de-risking.
  • BESS Plans: Evaluation ongoing with technology partners for containerized Battery Energy Storage System manufacturing, to be housed in a separate subsidiary.
  • Vision 2030: Long-term plan to build 10 GW module capacity, 10 GW cell capacity, 10 GW BESS infrastructure, and 2 GW wafer/ingot capacity. Aligned with an INR 4,000 crore MoU signed with the Government of Gujarat.
  • ALMM Impact: Addressed the impact of ALMM-2 (ALCM) policy clarification on May 25, 2026, causing temporary delays but no order cancellations. Company is prepared for both ALMM compliant and non-compliant scenarios.

Additional Notes Section

  • The document submitted is the transcript of the conference call, enclosed with the regulatory filing.
  • The transcript contains detailed financial figures for Q1 FY27, as summarized above.
  • The call included a Q&A session where management addressed queries on capex, inventory, ALMM, BESS strategy, exports, cell manufacturing challenges, and market dynamics.